EC Gives New Consortium $3.8M to Develop High-throughput Technology for Biomarker Detection

Called Proactive, the consortium will use the funds to build out Olink Bioscience's proximity ligation assays to improve the detection of biomarkers for colorectal cancer in plasma.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories